DETECTION OF BLADDER-TUMORS BY IMMUNOSTAINING OF THE LEWIS-X ANTIGEN IN CELLS FROM VOIDED URINE

被引:57
|
作者
GOLIJANIN, D [1 ]
SHERMAN, Y [1 ]
SHAPIRO, A [1 ]
PODE, D [1 ]
机构
[1] HEBREW UNIV JERUSALEM,HADASSAH MED CTR,DEPT PATHOL,JERUSALEM,ISRAEL
关键词
D O I
10.1016/S0090-4295(99)80189-7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. A study was made to determine the sensitivity and specificity of immunostaining of the Lewis X antigen in exfoliated urothelial cells from voided urine, for the detection and surveillance of bladder tumors. Methods. Three consecutive voided urine specimens were obtained from 101 patients, 78 of whom were under surveillance because of a history of bladder tumors, and 23 were being evaluated because of hematuria or irritative urinary symptoms. Indirect immunoperoxidase staining of two urine samples was done on cytocentrifuge slides, using the P12 monoclorial antibody against the Lewis X antigen. The diagnosis of the presence of a urothelial tumor was made if more than 5% of the cells showed a typical red-brown staining. Cytopathologic examination of the third urine specimen was done according to Papanicolaou. Each patient underwent cystoscopy, and biopsies were obtained whenever there was endoscopic evidence of bladder tumors or carcinoma in situ. Results. Cystoscopy and biopsies revealed transitional cell carcinoma in 32 patients, whereas 69 patients had no evidence of bladder tumors. Immunocytology of one urine sample showed true-positive results in 26 of the 32 patients with bladder tumors, corresponding to a sensitivity of 81.25%. When two samples were examined, a sensitivity of 97% and a specificity of 85.5% were obtained. When the results of cytology and immunocytology were combined, sensitivity reached 100%. High-grade and low-grade transitional cell tumors were detected with equal efficiency. Conclusions. The use of P12 monoclonal antibody for evaluation of Lewis X reactivity in cytologic preparations from multiple voided urine specimens can improve the sensitivity of noninvasive detection of bladder cancer. The technique may ultimately replace cystoscopy in monitoring therapeutic response and tumor recurrence.
引用
收藏
页码:173 / 177
页数:5
相关论文
共 50 条
  • [32] Detection of Urothelial Bladder Cancer Cells in Voided Urine Can Be Improved by a Combination of Cytology and Standardized Microsatellite Analysis
    Wild, Peter J.
    Fuchs, Thomas
    Stoehr, Robert
    Zimmermann, Dieter
    Frigerio, Simona
    Padberg, Barbara
    Steiner, Inbal
    Zwarthoff, Ellen C.
    Burger, Maximilian
    Denzinger, Stefan
    Hofstaedter, Ferdinand
    Kristiansen, Glen
    Hermanns, Thomas
    Seifert, Hans-Helge
    Provenzano, Maurizio
    Sulser, Tullio
    Roth, Volker
    Buhmann, Joachim M.
    Moch, Holger
    Hartmann, Arndt
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (06) : 1798 - 1806
  • [33] Noninvasive detection and prediction of bladder cancer by fluorescence in situ hybridization analysis of exfoliated urothelial cells in voided urine
    Ishiwata, S
    Takahashi, S
    Homma, Y
    Tanaka, Y
    Kameyama, S
    Hosaka, Y
    Kitamura, T
    UROLOGY, 2001, 57 (04) : 811 - 815
  • [34] Preliminary report of the clinical performance of a new urinary bladder cancer antigen test: comparison to voided urine cytology in the detection of transitional cell carcinoma of the bladder
    Sumi, S
    Arai, K
    Kitahara, S
    Yoshida, K
    CLINICA CHIMICA ACTA, 2000, 296 (1-2) : 111 - 120
  • [35] AN FGFR3 MUTATION IN CELLS OBTAINED FROM VOIDED URINE IS A STRONG PREDICTOR OF RECURRENT BLADDER CANCER
    Zuiverloon, T. C. M.
    Van der Aa, M. N. M.
    Van Der Kwast, T. H.
    Steyerberg, E. W.
    Bangma, C. H.
    Zwarthoff, E. C.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 372 - 372
  • [36] An FGFR3 mutation in cells obtained from voided urine is a strong predictor of recurrent bladder cancer
    Zwarthoff, Ellen
    van der Aa, Madelon
    van der Kwast, Theo
    Steyerberg, Ewout
    Bangma, Chris
    Zuiverloon, Tahlita
    CANCER RESEARCH, 2009, 69
  • [37] Diagnostic performance of the urinary bladder carcinoma antigen ELISA test and multiparametric DNA/cytokeratin flow cytometry in urine voided samples from patients with bladder carcinoma
    Sánchez-Carbayo, M
    Ciudad, J
    Urrutia, M
    Navajo, JA
    Orfao, A
    CANCER, 2001, 92 (11) : 2811 - 2819
  • [38] ANALYSIS OF DNA CONTENT AND INTEGRITY IN CELLS EXTRACTED FROM BLADDER WASHING AND VOIDED URINE SPECIMENS, IN BLADDER-CANCER PATIENTS, USING THE COMET ASSAY
    MCKELVEY, VJ
    BUTLER, M
    STEWART, LH
    MUTATION RESEARCH, 1992, 271 (02): : 163 - 163
  • [39] Detection of functional antigen-specific T cells from urine of non-muscle invasive bladder cancer patients
    Pieraerts, Claire
    Martin, Virginie
    Jichlinski, Patrice
    Nardelli-Haefliger, Denise
    Derre, Laurent
    ONCOIMMUNOLOGY, 2012, 1 (05): : 694 - 698
  • [40] Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer
    Kinoshita, H
    Ogawa, O
    Kakehi, Y
    Mishina, M
    Mitsumori, K
    Itoh, N
    Yamada, H
    Terachi, T
    Yoshida, O
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (10) : 724 - 730